Star Health Q4 Review - Healthy Premium Growth, Profitability Guidance: Motilal Oswal

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy..Motilal Oswal Report.Star Health and Allied Insurance Company Ltd.’s net underwriting loss for Q4 FY22 came in at Rs 2.2 billion versus our estimate of Rs 2.9 billion of underwriting profit. The disappointment was mainly led by 10% lower-than-expected gross written premium at Rs 36.9 billion (up 13% YoY/up 36% QoQ). Net earned premium at Rs 26.2 billion was 21% below our expectation due to higher unexpired risk reserve. Incurred claims at Rs 17.8 billion (34% better than expectation) saw a sharp decline of 33% sequentially. Resultantly, incurred claims ratio came in at 68.1% versus 209.4% in Q4 FY21 and 104.6% in Q3 FY22. Overall, Star Health's combined ratio stood at 98.4% (12.2% better than expectation) versus 231% in Q4 FY21 and 136% in Q3 FY22..Click on the attachment to read the full report:.DISCLAIMERThis report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint..Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Star Health Q4 Review - Healthy Premium Growth, Profitability Guidance: Motilal Oswal

Star Health Q4 Review - Healthy Premium Growth, Profitability Guidance: Motilal Oswal

Choose a plan